SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    0 We conducted a study to determine if a five-item pediatric cough questionnaire ( PCQ ) is a valid and reliable means of measuring cough-specific quality of life in children .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    0 We_PPIS2 conducted_VVD a_AT1 study_NN1 to_TO determine_VVI if_CSW@_CS a_AT1 five-item_JJ pediatric_JJ cough_NN1 questionnaire_NN1 (_Y PCQ_NP1 )_Y is_VBZ a_AT1 valid_JJ and_CC reliable_JJ means_NN of_IO measuring_VVG cough-specific_JJ quality_NN1 of_IO life_NN1 in_II children_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    1 The five questions , which are answered by the child 's parent or caregiver , cover cough frequency ( Q1 ) , sleep disturbance of the child ( Q2 ) , sleep disturbance of the parent ( Q3 ) , cough severity ( Q4 ) , and the degree of bothersomeness to the child ( Q5 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    1 The_AT five_MC questions_NN2 ,_Y which_DDQ are_VBR answered_VVN by_II the_AT child_NN1 's_GE parent_NN1 or_CC caregiver_NN1_VV0 ,_Y cover_VV0_NN1 cough_NN1_VV0 frequency_NN1 (_Y Q1_FO )_Y ,_Y sleep_VV0_NN1 disturbance_NN1 of_IO the_AT child_NN1 (_Y Q2_FO )_Y ,_Y sleep_VV0_NN1 disturbance_NN1 of_IO the_AT parent_NN1 (_Y Q3_FO )_Y ,_Y cough_VV0_NN1 severity_NN1 (_Y Q4_FO )_Y ,_Y and_CC the_AT degree_NN1 of_IO bothersomeness_NN1 to_II the_AT child_NN1 (_Y Q5_FO )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    2 Each of the five items was scored on a 6-point Likert scale .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    2 Each_DD1 of_IO the_AT five_MC items_NN2 was_VBDZ scored_VVN on_II a_AT1 6-point_JJ_NN1 Likert_NP1 scale_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    3 The PCQ was administered three times .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    3 The_AT PCQ_NP1 was_VBDZ administered_VVN three_MC times_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    4 The first occurred when the parent telephoned to schedule an appointment for the child at a pediatric pulmonology outpatient clinic for a chief complaint of cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    4 The_AT first_MD occurred_VVD_VVN@ when_RRQ_CS the_AT parent_NN1 telephoned_VVD to_TO schedule_VVI an_AT1 appointment_NN1 for_IF the_AT child_NN1 at_II a_AT1 pediatric_JJ pulmonology_NN1 outpatient_NN1 clinic_NN1 for_IF a_AT1 chief_JJ_NN1 complaint_NN1 of_IO cough_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    5 The second PCQ was administered within 2 weeks of the first but before any treatment had been instituted so that test-retest reliability could be assessed .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    5 The_AT second_MD_NNT1 PCQ_NP1 was_VBDZ administered_VVN within_II 2_MC weeks_NNT2 of_IO the_AT first_MD but_CCB before_CS_II any_DD treatment_NN1 had_VHD been_VBN instituted_VVN so_CS21 that_CS22 test-retest_JJ reliability_NN1 could_VM be_VBI assessed_VVN ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    6 Each child was then diagnosed and treated in accordance with standard care practices .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    6 Each_DD1 child_NN1 was_VBDZ then_RT diagnosed_VVN_VVD and_CC treated_VVN in_II31 accordance_II32 with_II33 standard_JJ_NN1 care_NN1 practices_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    7 The third PCQ was administered 3 weeks after the second to determine if the child 's cough had changed following treatment .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    7 The_AT third_MD PCQ_NP1 was_VBDZ administered_VVN 3_MC weeks_NNT2 after_II_CS the_AT second_NNT1_MD to_TO determine_VVI if_CSW@_CS the_AT child_NN1 's_GE cough_NN1 had_VHD changed_VVN following_II@_VVG_JJ@ treatment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    8 Also , at the second and third encounters , parents were asked to provide their global assessment of whether their child 's cough had improved , worsened , or stayed the same since the previous encounter .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    8 Also_RR ,_Y at_II the_AT second_MD_NNT1 and_CC third_MD encounters_NN2_VVZ ,_Y parents_NN2 were_VBDR asked_VVN@ to_TO provide_VVI their_APPGE global_JJ assessment_NN1 of_IO whether_CSW their_APPGE child_NN1 's_GE cough_NN1 had_VHD improved_VVN ,_Y worsened_VVD_VVN ,_Y or_CC stayed_VVD the_AT same_DA since_CS_II@ the_AT previous_JJ encounter_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0    9 The parents of 120 children ( 70 boys and 50 girls ; mean age : 6.8 yr ) completed all three PCQs .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0    9 The_AT parents_NN2 of_IO 120_MC children_NN2 (_Y 70_MC boys_NN2 and_CC 50_MC girls_NN2 ;_Y mean_JJ_VV0 age_NN1 :_Y 6.8_MC yr_NNU )_Y completed_VVD all_DB_RR@ three_MC PCQs_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   10 Test-retest reliability was established ( p &lt; 0.001 ) for each of the five PCQ questions by Spearman correlation analysis ( Q1 : r = 0.5 ; Q2 : r = 0.38 ; Q3 : r = 0.42 ; Q4 : r = 0.53 ; Q5 : r = 0.5 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   10 Test-retest_JJ_NN1 reliability_NN1 was_VBDZ established_VVN (_Y p_ZZ1 &lt;_FO 0.001_MC )_Y for_IF each_DD1 of_IO the_AT five_MC PCQ_NP1 questions_NN2 by_II Spearman_NP1_NN1 correlation_NN1 analysis_NN1 (_Y Q1_FO :_Y r_ZZ1 =_FO 0.5_MC ;_Y Q2_FO :_Y r_ZZ1 =_FO 0.38_MC ;_Y Q3_FO :_Y r_ZZ1 =_FO 0.42_MC ;_Y Q4_FO :_Y r_ZZ1 =_FO 0.53_MC ;_Y Q5_FO :_Y r_ZZ1 =_FO 0.5_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   11 Other statistical analyses confirmed the PCQ 's internal consistency , discriminant validity , and convergent validity .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   11 Other_JJ statistical_JJ analyses_NN2 confirmed_VVD_VVN the_AT PCQ_NP1 's_GE internal_JJ consistency_NN1 ,_Y discriminant_JJ validity_NN1 ,_Y and_CC convergent_JJ validity_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   12 Based on our findings , we conclude that the PCQ is a valid and reliable instrument with which to follow children with chronic cough longitudinally .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   12 Based_VVN on_II our_APPGE findings_NN2 ,_Y we_PPIS2 conclude_VV0 that_CST the_AT PCQ_NP1 is_VBZ a_AT1 valid_JJ and_CC reliable_JJ instrument_NN1 with_IW which_DDQ to_TO follow_VVI children_NN2 with_IW chronic_JJ cough_NN1 longitudinally_RR ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   13 Cough is both an important physiologic component of lung defense and a cardinal indicator of disease .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   13 Cough_NN1_VV0 is_VBZ both_RR an_AT1 important_JJ physiologic_JJ component_NN1 of_IO lung_NN1 defense_NN1 and_CC a_AT1 cardinal_JJ_NN1 indicator_NN1 of_IO disease_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   14 In the United States , cough remains the most common the second most common reason for medical visits by children. ( n1 , n2 ) The estimated prevalence of cough in children is 5 to 15%. ( n1 , n2 ) Overall , chronic cough has been reported to account for 10 to 38% of visits to pulmonologists ' outpatient practices. ( n3-n6 ) The metamorphosis of coughing from a normal to a pathologic event can be measured in terms of frequency , character , and duration. ( n3 , n4 ) Each of these characteristics , along with a child 's age , informs our decisions about diagnosis and management .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   14 In_II the_AT United_NP1 States_NP1 ,_Y cough_NN1 remains_VVZ the_AT most_RGT common_JJ the_AT second_MD most_RGT common_JJ reason_NN1 for_IF medical_JJ visits_NN2 by_II children._NNU (_Y n1_FO ,_Y n2_FO )_Y The_AT estimated_JJ@ prevalence_NN1 of_IO cough_NN1 in_II children_NN2 is_VBZ 5_MC to_II 15%._FO (_Y n1_FO ,_Y n2_FO )_Y Overall_RR_NN1_JJ ,_Y chronic_JJ cough_NN1 has_VHZ been_VBN reported_VVN to_TO account_VVI for_IF 10_MC to_II 38%_NNU of_IO visits_NN2 to_II pulmonologists_NN2 '_GE outpatient_NN1 practices._NNU (_Y n3-n6_NN1_JJ )_Y The_AT metamorphosis_NN1 of_IO coughing_VVG from_II a_AT1 normal_JJ to_II a_AT1 pathologic_JJ event_NN1 can_VM be_VBI measured_VVN in_II31 terms_II32 of_II33 frequency_NN1 ,_Y character_NN1 ,_Y and_CC duration._NNU (_Y n3_FO ,_Y n4_FO )_Y Each_DD1 of_IO these_DD2 characteristics_NN2 ,_Y along_II21 with_II22 a_AT1 child_NN1 's_GE age_NN1 ,_Y informs_VVZ our_APPGE decisions_NN2 about_II diagnosis_NN1 and_CC management_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   15 For children with chronic cough , defined as cough that lasts for more than 3 weeks , n7 the differential diagnosis is broad ; it includes self-limited , persistent , and chronic diseases .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   15 For_IF children_NN2 with_IW chronic_JJ cough_NN1 ,_Y defined_VVN_VVD as_CSA_II@ cough_NN1 that_CST_DD1 lasts_VVZ for_IF more_DAR than_CSN 3_MC weeks_NNT2 ,_Y n7_FO the_AT differential_JJ_NN1 diagnosis_NN1 is_VBZ broad_JJ ;_Y it_PPH1 includes_VVZ self-limited_NN1_JJ ,_Y persistent_JJ ,_Y and_CC chronic_JJ diseases_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   16 An isolated cough in an otherwise healthy child may arise secondary to recurrent viral bronchiolitis , a postinfection etiology , pertussis , cough variant asthma , or postnasal drip , or it may be psychogenic .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   16 An_AT1 isolated_JJ cough_NN1 in_II an_AT1 otherwise_RR healthy_JJ child_NN1 may_VM arise_VVI secondary_NN1_JJ to_II recurrent_JJ viral_JJ bronchiolitis_NN1 ,_Y a_AT1 postinfection_NN1 etiology_NN1 ,_Y pertussis_NN1 ,_Y cough_VV0_NN1 variant_NN1 asthma_NN1 ,_Y or_CC postnasal_NN1_JJ@ drip_NN1 ,_Y or_CC it_PPH1 may_VM be_VBI psychogenic_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   17 Possible significant underlying causes of cough include cystic fibrosis , primary ciliary dyskinesia , immune deficiencies , chronic bronchitis , extrinsic compression of the airway , and interstitial lung disease. n8 Healthy children experience an average of 10 episodes of cough per 24 hours. n9 Acute respiratory infections can occur in healthy children between 5 and 8 times per year .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   17 Possible_JJ significant_JJ underlying_JJ causes_NN2 of_IO cough_NN1 include_VV0 cystic_JJ fibrosis_NN1 ,_Y primary_JJ ciliary_JJ_NN1 dyskinesia_NN1 ,_Y immune_JJ deficiencies_NN2 ,_Y chronic_JJ bronchitis_NN1 ,_Y extrinsic_JJ compression_NN1 of_IO the_AT airway_NN1 ,_Y and_CC interstitial_JJ lung_NN1 disease._NNU n8_FO Healthy_JJ children_NN2 experience_VV0 an_AT1 average_NN1 of_IO 10_MC episodes_NN2 of_IO cough_NN1 per_II 24_MC hours._NNU n9_FO Acute_JJ respiratory_JJ infections_NN2 can_VM occur_VVI in_II_RP@ healthy_JJ children_NN2 between_II 5_MC and_CC 8_MC times_NNT2 per_II year_NNT1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   18 With each episode , a child may cough for more than a week .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   18 With_IW each_DD1 episode_NN1 ,_Y a_AT1 child_NN1 may_VM cough_VVI for_IF more_DAR than_CSN a_AT1 week_NNT1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   19 In a given year , this could translate to approximately 50 days of cough. n10 Even when cough is self-limited , as it is in most cases , it can still be disruptive to both children and their parents if it leads to physical and/or psychological morbidity. n11 Cough can interfere with the daily activities and sleep of children and their parents , and its effects can be measured in terms of days missed from school and lost from work .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   19 In_II a_AT1 given_JJ@ year_NNT1 ,_Y this_DD1 could_VM translate_VVI to_II_TO approximately_RR 50_MC days_NNT2 of_IO cough._NNU n10_FO Even_CS21 when_CS22 cough_NN1 is_VBZ self-limited_JJ_NN1 ,_Y as_CSA it_PPH1 is_VBZ in_II most_DAT cases_NN2 ,_Y it_PPH1 can_VM still_RR be_VBI disruptive_JJ to_II both_DB2 children_NN2 and_CC their_APPGE parents_NN2 if_CS it_PPH1 leads_VVZ to_II physical_JJ and/or_CC psychological_JJ morbidity._NNU n11_FO Cough_NN1_VV0 can_VM interfere_VVI with_IW the_AT daily_JJ activities_NN2 and_CC sleep_NN1 of_IO children_NN2 and_CC their_APPGE parents_NN2 ,_Y and_CC its_Z' effects_NN2 can_VM be_VBI measured_VVN in_II31 terms_II32 of_II33 days_NNT2 missed_VVN_VVD from_II school_NN1 and_CC lost_VVN_VVD from_II work_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   20 The impact of cough can also be measured in economic terms , and that impact is quite large .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   20 The_AT impact_NN1 of_IO cough_NN1 can_VM also_RR be_VBI measured_VVN in_II economic_JJ terms_NN2 ,_Y and_CC that_DD1 impact_NN1 is_VBZ quite_RG large_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   21 Consumers spend billions of dollars per year on over-the-counter medications for cough. ( n12 , n13 ) The annual aggregate cost of treating cough in the United States in the 1980s exceeded $1 billion. n14 certainly underestimates costs today .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   21 Consumers_NN2 spend_VV0 billions_M of_IO dollars_NNU2 per_II year_NNT1 on_II over-the-counter_JJ_NN1 medications_NN2 for_IF cough._NNU (_Y n12_FO ,_Y n13_FO )_Y The_AT annual_JJ aggregate_JJ_NN1 cost_NN1 of_IO treating_VVG cough_NN1_VV0 in_II the_AT United_NP1 States_NP1 in_II the_AT 1980s_MC2 exceeded_VVD $1_NNU billion._ZZ n14_FO certainly_RR underestimates_VVZ costs_NN2_VVZ today_RT ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   22 In the United Kingdom , where the prevalence of troublesome cough is 20% , patients consume 75 million doses of over-the-counter antitussive medications annually. n15 Despite the great socioeconomic burden of chronic cough , there is a paucity of objective and well-validated measures of quality-of-life outcomes. n16 In 2004 , Paul et al published a five-item pediatric cough questionnaire ( PCQ ) to assess cough-specific quality-of-life issues for children and their parents. n17 Until now , the PCQ has not been formally validated , although the study by Paul et al did demonstrate some aspects of discriminant validity .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   22 In_II the_AT United_NP1 Kingdom_NP1 ,_Y where_CS_RRQ the_AT prevalence_NN1 of_IO troublesome_JJ cough_NN1 is_VBZ 20%_NNU ,_Y patients_NN2 consume_VV0 75_MC million_M1 doses_NN2 of_IO over-the-counter_JJ antitussive_JJ medications_NN2 annually._NNU n15_FO Despite_II the_AT great_JJ socioeconomic_JJ burden_NN1 of_IO chronic_JJ cough_NN1 ,_Y there_EX is_VBZ a_AT1 paucity_NN1 of_IO objective_NN1_JJ and_CC well-validated_JJ measures_NN2 of_IO quality-of-life_JJ_NN1 outcomes._NNU n16_FO In_II 2004_MC ,_Y Paul_NP1 et_RA21 al_RA22 published_VVD a_AT1 five-item_JJ pediatric_JJ cough_NN1 questionnaire_NN1 (_Y PCQ_NP1 )_Y to_TO assess_VVI cough-specific_JJ quality-of-life_JJ_NN1 issues_NN2 for_IF children_NN2 and_CC their_APPGE parents._NNU n17_FO Until_II now_RT ,_Y the_AT PCQ_NP1 has_VHZ not_XX been_VBN formally_RR validated_VVN ,_Y although_CS the_AT study_NN1 by_II Paul_NP1 et_RA21 al_RA22 did_VDD demonstrate_VVI some_DD aspects_NN2 of_IO discriminant_JJ validity_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   23 We conducted a study to determine the validity and reliability of our slightly modified version of the PCQ that was developed by Paul et al. n17 Subjects and methods The goal of our study was to test the psychometric properties of the PCQ in the parents of children with chronic cough in the greater Boston area .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   23 We_PPIS2 conducted_VVD a_AT1 study_NN1 to_TO determine_VVI the_AT validity_NN1 and_CC reliability_NN1 of_IO our_APPGE slightly_RR modified_JJ_VVN version_NN1 of_IO the_AT PCQ_NP1 that_DD1_CST was_VBDZ developed_VVN by_II Paul_NP1 et_RA21 al._RA22 n17_FO Subjects_NN2 and_CC methods_NN2 The_AT goal_NN1 of_IO our_APPGE study_NN1 was_VBDZ to_TO test_VVI the_AT psychometric_JJ properties_NN2 of_IO the_AT PCQ_NP1 in_II the_AT parents_NN2 of_IO children_NN2 with_IW chronic_JJ cough_NN1 in_II the_AT greater_JJR Boston_NP1 area_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   24 Thus , we administered the PCQ to the parents of children who presented to the pediatric pulmonology office at the Massachusetts General Hospital for Children or at one of its In addition to the questionnaire itself , we obtained demographic information and information on underlying causes .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   24 Thus_RR ,_Y we_PPIS2 administered_VVD the_AT PCQ_NP1 to_II the_AT parents_NN2 of_IO children_NN2 who_PNQS presented_VVD to_II the_AT pediatric_JJ pulmonology_NN1 office_NN1 at_II the_AT Massachusetts_NP1 General_JJ_NN1 Hospital_NN1 for_IF Children_NN2 or_CC at_II one_MC1 of_IO its_Z' In_II31 addition_II32 to_II33 the_AT questionnaire_NN1 itself_PPX1 ,_Y we_PPIS2 obtained_VVD demographic_JJ information_NN1 and_CC information_NN1 on_II underlying_JJ_VVG causes_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   25 Because the PCQ has not been translated into Spanish , we focused on English-speaking parents , including those whose English was limited but who were still able to read and understand the PCQ .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   25 Because_CS the_AT PCQ_NP1 has_VHZ not_XX been_VBN translated_VVN into_II Spanish_JJ_NN1@ ,_Y we_PPIS2 focused_VVD on_II_RP@ English-speaking_JJ parents_NN2 ,_Y including_II_VVG@ those_DD2 whose_DDQGE English_NN1 was_VBDZ limited_VVN_JJ but_CCB who_PNQS were_VBDR still_RR able_JK to_TO read_VVI and_CC understand_VVI the_AT PCQ_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   26 The answers to the five questions were scored on a 6-point Likert scale from 0 through 5 , and possible overall scores ranged from 0 to 25 ; lower scores indicated a poorer cough-related quality of life ( see " The five-item pediatric cough questionnaire " ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   26 The_AT answers_NN2 to_II the_AT five_MC questions_NN2 were_VBDR scored_VVN on_II a_AT1 6-point_JJ_NN1 Likert_NP1 scale_NN1 from_II 0_MC through_II 5_MC ,_Y and_CC possible_JJ overall_JJ_NN1 scores_NN2 ranged_VVN_VVD from_II 0_MC to_II 25_MC ;_Y lower_JJR scores_NN2 indicated_VVD_VVN a_AT1 poorer_JJR cough-related_JJ_NN1 quality_NN1 of_IO life_NN1 (_Y see_VV0 "_Y The_AT five-item_JJ_NN1 pediatric_JJ cough_NN1 questionnaire_NN1 "_Y )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   27 Our version of the PCQ differed slightly from that first published by Paul et al , n17 which was based on a 7-point Likert scale .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   27 Our_APPGE version_NN1 of_IO the_AT PCQ_NP1 differed_VVD slightly_RR from_II that_DD1 first_MD published_VVN by_II Paul_NP1 et_RA21 al_RA22 ,_Y n17_FO which_DDQ was_VBDZ based_VVN on_II a_AT1 7-point_JJ_NN1 Likert_NP1 scale_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   28 We deleted one of their possible answers ( " a lot " ) because we felt it is synonymous with another of their possible answers ( " very much " ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   28 We_PPIS2 deleted_VVD one_MC1 of_IO their_APPGE possible_JJ answers_NN2 (_Y "_Y a_RR21@_AT1 lot_RR22_NN1 "_Y )_Y because_CS we_PPIS2 felt_VVD it_PPH1 is_VBZ synonymous_JJ with_IW another_DD1 of_IO their_APPGE possible_JJ answers_NN2 (_Y "_Y very_RG much_RR "_Y )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   29 We also made some minor grammatical changes .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   29 We_PPIS2 also_RR made_VVD some_DD minor_JJ grammatical_JJ changes_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   30 The PCQ was administered three times .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   30 The_AT PCQ_NP1 was_VBDZ administered_VVN three_MC times_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   31 The first survey was conducted when a parent telephoned to make the initial office appointment for his or her ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   31 The_AT first_MD survey_NN1 was_VBDZ conducted_VVN when_CS_RRQ a_AT1 parent_NN1 telephoned_VVD to_TO make_VVI the_AT initial_JJ_NN1 office_NN1 appointment_NN1 for_IF his_APPGE or_CC her_APPGE )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   32 The appointment was then scheduled for within 2 weeks of the phone call .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   32 The_AT appointment_NN1 was_VBDZ then_RT scheduled_VVN for_IF within_II 2_MC weeks_NNT2 of_IO the_AT phone_NN1 call_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   33 The second survey was conducted at the office visit before any treatment had been instituted ( TP2 ) ; the purpose of the second survey was to gauge test-retest reliability .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   33 The_AT second_MD survey_NN1 was_VBDZ conducted_VVN at_II the_AT office_NN1 visit_NN1_VV0 before_II_CS any_DD treatment_NN1 had_VHD been_VBN instituted_VVN (_Y TP2_FO )_Y ;_Y the_AT purpose_NN1 of_IO the_AT second_MD survey_NN1 was_VBDZ to_II gauge_NN1 test-retest_NN1_JJ reliability_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   34 The child was then evaluated and treated according to standard care practices .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   34 The_AT child_NN1 was_VBDZ then_RT evaluated_VVN_VVD and_CC treated_VVN according_II21 to_II22 standard_JJ_NN1 care_NN1 practices_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   35 The third survey was conducted by phone 3 weeks after the office visit ( TP3 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   35 The_AT third_MD survey_NN1 was_VBDZ conducted_VVN by_II phone_NN1 3_MC weeks_NNT2 after_II_CS the_AT office_NN1 visit_NN1 (_Y TP3_FO )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   36 In addition , at the second and third encounters , parents were also asked if their child 's cough had improved , worsened , or stayed the same since the previous visit , and their answers were compared with the PCQ results .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   36 In_RR21 addition_RR22 ,_Y at_II the_AT second_MD_NNT1 and_CC third_MD encounters_NN2_VVZ ,_Y parents_NN2 were_VBDR also_RR asked_VVN if_CS_CSW@ their_APPGE child_NN1 's_GE cough_NN1 had_VHD improved_VVN ,_Y worsened_VVD_VVN ,_Y or_CC stayed_VVD the_AT same_DA since_CS_II@ the_AT previous_JJ visit_NN1 ,_Y and_CC their_APPGE answers_NN2 were_VBDR compared_VVN with_IW the_AT PCQ_NP1 results_NN2_VVZ@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   37 Reliability measures .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   37 Reliability_NN1 measures_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   38 Two measures of reliability were assessed : the Spearman correlation for test-retest reliability and the Cronbach alpha test for internal consistency .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   38 Two_MC measures_NN2 of_IO reliability_NN1 were_VBDR assessed_VVN :_Y the_AT Spearman_NN1_NP1 correlation_NN1 for_IF test-retest_JJ_NN1 reliability_NN1 and_CC the_AT Cronbach_NP1 alpha_NN1 test_NN1_VV0 for_IF internal_JJ consistency_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   39 The Spearman correlation for test-test reliability is used when an instrument is administered to a population at two distinct times that are separated by a relatively short interval during which no intervention is given. n18 The assumption is that a patient 's health status will be there should be a robust correlation between the findings of both tests -- or in other words , no statistically significant difference between them .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   39 The_AT Spearman_NN1_NP1 correlation_NN1 for_IF test-test_JJ_NN1 reliability_NN1 is_VBZ used_VVN when_CS_RRQ an_AT1 instrument_NN1 is_VBZ administered_VVN to_II a_AT1 population_NN1 at_II two_MC distinct_JJ times_NNT2 that_CST are_VBR separated_VVN by_II a_AT1 relatively_RR short_JJ interval_NN1 during_II which_DDQ no_AT intervention_NN1 is_VBZ given._NNU n18_FO The_AT assumption_NN1 is_VBZ that_CST a_AT1 patient_NN1 's_GE health_NN1 status_NN1 will_VM be_VBI there_EX should_VM be_VBI a_AT1 robust_JJ correlation_NN1 between_II the_AT findings_NN2 of_IO both_DB2 tests_NN2 --_NN1_JJ or_CC in_II other_JJ words_NN2 ,_Y no_UH statistically_RR significant_JJ difference_NN1 between_II them_PPHO2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   40 The Cronbach alpha test is used to determine an instrument 's reliability when one item is deleted from the calculations .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   40 The_AT Cronbach_NP1 alpha_NN1 test_NN1 is_VBZ used_VVN to_TO determine_VVI an_AT1 instrument_NN1 's_GE reliability_NN1 when_CS_RRQ one_MC1 item_NN1 is_VBZ deleted_VVN from_II the_AT calculations_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   41 A finding that the Cronbach alpha value for the remaining items increases significantly after an item is deleted suggests that the deleted item may be less relevant than other items. n18 Values greater than 0.8 are assumed to reflect instrument consistency .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   41 A_AT1_ZZ1 finding_NN1_VVG that_CST the_AT Cronbach_NP1 alpha_NN1 value_NN1 for_IF the_AT remaining_JJ items_NN2 increases_VVZ significantly_RR after_II_CS an_AT1 item_NN1 is_VBZ deleted_VVN suggests_VVZ that_CST the_AT deleted_JJ@ item_NN1 may_VM be_VBI less_RGR relevant_JJ than_CSN other_JJ items._NNU n18_FO Values_VVZ@_NN2 greater_JJR than_CSN 0.8_MC are_VBR assumed_VVN to_TO reflect_VVI instrument_NN1 consistency_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   42 Validity measures .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   42 Validity_NN1 measures_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   43 We measured both discriminant validity and convergence validity .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   43 We_PPIS2 measured_VVD both_RR_DB2 discriminant_JJ validity_NN1 and_CC convergence_NN1 validity_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   44 The hypothesis with respect to the discriminant validity of the PCQ is that there should be a significant difference between mean TP1 and TP3 scores for children whose cough had either improved or worsened after treatment according to the parent 's global assessment .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   44 The_AT hypothesis_NN1 with_II31 respect_II32 to_II33 the_AT discriminant_JJ validity_NN1 of_IO the_AT PCQ_NP1 is_VBZ that_CST there_EX should_VM be_VBI a_AT1 significant_JJ difference_NN1 between_II mean_JJ_NN1@ TP1_FO and_CC TP3_FO scores_NN2_VVZ@ for_IF children_NN2 whose_DDQGE cough_NN1 had_VHD either_RR improved_VVN or_CC worsened_VVN_VVD after_II treatment_NN1 according_II21 to_II22 the_AT parent_NN1 's_GE global_JJ assessment_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   45 For convergent validity , the hypothesis is that there should not be a significant difference in the mean scores between TP1 and TP3 scores for children whose cough was unchanged after treatment according to the parents .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   45 For_IF convergent_JJ validity_NN1 ,_Y the_AT hypothesis_NN1 is_VBZ that_CST there_EX should_VM not_XX be_VBI a_AT1 significant_JJ difference_NN1 in_II the_AT mean_JJ scores_NN2 between_II TP1_FO and_CC TP3_FO scores_NN2_VVZ@ for_IF children_NN2 whose_DDQGE cough_NN1 was_VBDZ unchanged_JJ after_II_CS treatment_NN1 according_II21 to_II22 the_AT parents_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   46 Sample-size calculations .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   46 Sample-size_JJ calculations_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   47 We calculated that a sample size of when p is set at 0.05 ) in demonstrating a mean change of 3 points in overall PCQ scores .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   47 We_PPIS2 calculated_VVD that_CST a_AT1 sample_NN1 size_NN1 of_IO when_CS_RRQ p_ZZ1 is_VBZ set_VVN at_II 0.05_MC )_Y in_II demonstrating_VVG a_AT1 mean_JJ change_NN1 of_IO 3_MC points_NN2_VVZ in_II overall_JJ_NN1 PCQ_NP1 scores_NN2_VVZ@ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   48 Therefore , we selected a goal of 120 children as the size of our study population in order to be well above the calculated number .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   48 Therefore_RR ,_Y we_PPIS2 selected_VVD a_AT1 goal_NN1 of_IO 120_MC children_NN2 as_II_CSA the_AT size_NN1 of_IO our_APPGE study_NN1 population_NN1 in_BCL21 order_BCL22 to_TO be_VBI well_JJ above_II the_AT calculated_JJ@ number_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   49 Results We administered the PCQ to the parents of 120 children -- 70 boys and 50 girls aged 1 to 18 years ( mean : 6.8 5.1 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   49 Results_NN2 We_PPIS2 administered_VVD@ the_AT PCQ_NP1 to_II the_AT parents_NN2 of_IO 120_MC children_NN2 --_NN1_JJ 70_MC boys_NN2 and_CC 50_MC girls_NN2 aged_II@_VVN_VVD@ 1_MC1 to_II 18_MC years_NNT2 (_Y mean_VV0 :_Y 6.8_MC 5.1_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   50 The range of diagnoses included cough in 60 children ( 50% ) , asthma in 52 ( 43.3% ) , bronchitis in 3 ( 2.5% ) , cystic fibrosis in 3 , and pneumonia in 2 ( 1.7% ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   50 The_AT range_NN1 of_IO diagnoses_NN2 included_VVD_VVN cough_NN1_VV0 in_II 60_MC children_NN2 (_Y 50%_NNU )_Y ,_Y asthma_NN1 in_II 52_MC (_Y 43.3%_FO )_Y ,_Y bronchitis_NN1 in_II 3_MC (_Y 2.5%_FO )_Y ,_Y cystic_JJ fibrosis_NN1 in_II 3_MC ,_Y and_CC pneumonia_NN1 in_II 2_MC (_Y 1.7%_FO )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   51 Reliability .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   51 Reliability_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   52 The Spearman correlation analysis indicated good test-retest reliability ( p &lt; 0.001 ) ( table 1 ) , and the Cronbach alpha analysis indicated good internal consistency ( =0.88 ) ( table 2 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   52 The_AT Spearman_NN1_NP1 correlation_NN1 analysis_NN1 indicated_VVD_VVN good_JJ test-retest_JJ_NN1 reliability_NN1 (_Y p_ZZ1 &lt;_FO 0.001_MC )_Y (_Y table_NN1 1_MC1 )_Y ,_Y and_CC the_AT Cronbach_NP1 alpha_NN1 analysis_NN1 indicated_VVD_VVN good_JJ internal_JJ consistency_NN1 (_Y =0.88_FO )_Y (_Y table_NN1 2_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   53 Validity .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   53 Validity_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   54 Discriminant validity was established in that the mean PCQ score at TP3 ( post-treatment ) was significantly different from the mean score at TP1 ( pretreatment ) in cases in which parents reported that their child 's p &lt; 0.001 ) or worsened ( p = 0.003 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   54 Discriminant_JJ validity_NN1 was_VBDZ established_VVN in_II_CS21% that_DD1_CS22@ the_AT mean_JJ PCQ_NP1 score_NN1_VV0 at_II TP3_FO (_Y post-treatment_NN1_JJ )_Y was_VBDZ significantly_RR different_JJ from_II the_AT mean_JJ score_NN1 at_II TP1_FO (_Y pretreatment_NN1 )_Y in_II cases_NN2 in_II which_DDQ parents_NN2 reported_VVD_VVN that_CST their_APPGE child_NN1 's_GE p_ZZ1 &lt;_FO 0.001_MC )_Y or_CC worsened_VVN_VVD (_Y p_ZZ1 =_FO 0.003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   55 Convergent validity was established in that the mean PCQ score at TP3 was not significantly different from the TP1 score in cases in which parents reported that their child 's cough was unchanged after treatment ( p = 0.19 ) ( table 3 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   55 Convergent_JJ validity_NN1 was_VBDZ established_VVN in_II_CS21% that_DD1_CS22@ the_AT mean_JJ PCQ_NP1 score_NN1_VV0 at_II TP3_FO was_VBDZ not_XX significantly_RR different_JJ from_II the_AT TP1_FO score_VV0_NN1 in_II_RP@ cases_NN2 in_II which_DDQ parents_NN2 reported_VVD_VVN that_CST their_APPGE child_NN1 's_GE cough_NN1 was_VBDZ unchanged_JJ after_II_CS treatment_NN1 (_Y p_ZZ1 =_FO 0.19_MC )_Y (_Y table_NN1 3_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   56 Discussion Our review ' of the literature on chronic cough in adults and in children revealed the many difficulties associated with attempting to measure its prevalence and its impact on health-related quality of life .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   56 Discussion_NN1 Our_APPGE review_NN1 '_GE of_IO the_AT literature_NN1 on_II chronic_JJ cough_NN1 in_II adults_NN2 and_CC in_II children_NN2 revealed_VVD_VVN the_AT many_DA2 difficulties_NN2 associated_VVN with_IW attempting_VVG to_TO measure_VVI its_Z' prevalence_NN1 and_CC its_Z' impact_NN1 on_II health-related_JJ_NN1 quality_NN1 of_IO life_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   57 Some authors have used " cough meters " to count the number of coughs over a given period of time. ( n19 , n20 ) Others have used various questionnaires to evaluate different aspects of cough , wheezing , and other respiratory symptoms. ( n19-n23 ) Several cough-specific quality-of-life questionnaires have been developed , but they were designed to evaluate cough in adults rather than children. ( n11 , 22 , 23 ) In our study , we validated our slightly modified version of the pCQ developed by Paul et al. n17 Taken at face value , this PCQ in order for any such instrument to be considered scientifically valid , it must be shown to actually measure what it purports to measure ( validity ) , and it must do so consistently ( reliability ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   57 Some_DD authors_NN2 have_VH0 used_VVN "_Y cough_NN1_VV0 meters_NN2 "_Y to_TO count_VVI the_AT number_NN1 of_IO coughs_NN2 over_II a_AT1 given_JJ@ period_NN1 of_IO time._NNU (_Y n19_FO ,_Y n20_FO )_Y Others_NN2 have_VH0 used_VVN various_JJ questionnaires_NN2 to_TO evaluate_VVI different_JJ aspects_NN2 of_IO cough_NN1 ,_Y wheezing_VVG ,_Y and_CC other_JJ respiratory_JJ symptoms._NNU (_Y n19-n23_NN1_JJ )_Y Several_DA2 cough-specific_JJ quality-of-life_JJ_NN1 questionnaires_NN2 have_VH0 been_VBN developed_VVN ,_Y but_CCB they_PPHS2 were_VBDR designed_VVN to_TO evaluate_VVI cough_NN1_VV0 in_II adults_NN2 rather_II21 than_II22 children._NNU (_Y n11_FO ,_Y 22_MC ,_Y 23_MC )_Y In_II our_APPGE study_NN1 ,_Y we_PPIS2 validated_VVD our_APPGE slightly_RR modified_JJ_VVN version_NN1 of_IO the_AT pCQ_NNU developed_VVN by_II Paul_NP1 et_RA21 al._RA22 n17_FO Taken_VVN at_II face_NN1 value_NN1 ,_Y this_DD1 PCQ_NP1 in_BCL21 order_BCL22 for_IF any_DD such_DA instrument_NN1 to_TO be_VBI considered_VVN scientifically_RR valid_JJ ,_Y it_PPH1 must_VM be_VBI shown_VVN to_TO actually_RR measure_VVI what_DDQ it_PPH1 purports_VVZ to_TO measure_VVI (_Y validity_NN1 )_Y ,_Y and_CC it_PPH1 must_VM do_VDI so_RG_RR consistently_RR (_Y reliability_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   58 Furthermore , the instrument must demonstrate adequate psychometric properties , and it must include a meaningful scoring metric .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   58 Furthermore_RR ,_Y the_AT instrument_NN1 must_VM demonstrate_VVI adequate_JJ psychometric_JJ properties_NN2 ,_Y and_CC it_PPH1 must_VM include_VVI a_AT1 meaningful_JJ scoring_NN1_JJ@_VVG metric_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   59 Finally , it should not be onerous to administer or to complete .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   59 Finally_RR ,_Y it_PPH1 should_VM not_XX be_VBI onerous_JJ to_TO administer_VVI or_CC to_TO complete_VVI ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   60 Our sample size was sufficiently large to demonstrate statistical significance .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   60 Our_APPGE sample_NN1 size_NN1 was_VBDZ sufficiently_RR large_JJ to_TO demonstrate_VVI statistical_JJ significance_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   61 Our findings confirm that a 3-point difference in PCQ score is clinically significant .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   61 Our_APPGE findings_NN2 confirm_VV0 that_CST a_AT1 3-point_JJ_NN1 difference_NN1 in_II PCQ_NP1 score_NN1 is_VBZ clinically_RR significant_JJ ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   62 We established discriminant validity by proving the hypothesis that there should be a significant difference between mean PCQ scores at TP1 and TP3 in children whose cough had either improved ( p &lt; 0.001 ) or worsened ( p = 0.003 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   62 We_PPIS2 established_VVD discriminant_JJ validity_NN1 by_II proving_VVG the_AT hypothesis_NN1 that_CST there_EX should_VM be_VBI a_AT1 significant_JJ difference_NN1 between_II mean_JJ PCQ_NP1 scores_NN2_VVZ@ at_II TP1_FO and_CC TP3_FO in_II children_NN2 whose_DDQGE cough_NN1 had_VHD either_RR improved_VVN (_Y p_ZZ1 &lt;_FO 0.001_MC )_Y or_CC worsened_VVN_VVD (_Y p_ZZ1 =_FO 0.003_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   63 Convergent validity was established by proving the hypothesis that there should not be a significant difference in these scores when the child 's cough was unchanged ( p = 0.19 ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   63 Convergent_JJ validity_NN1 was_VBDZ established_VVN by_II proving_VVG the_AT hypothesis_NN1 that_CST there_EX should_VM not_XX be_VBI a_AT1 significant_JJ difference_NN1 in_II these_DD2 scores_NN2 when_RRQ_CS the_AT child_NN1 's_GE cough_NN1 was_VBDZ unchanged_JJ (_Y p_ZZ1 =_FO 0.19_MC )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   64 We also found that the PCQ demonstrated excellent reliability , that it is straightforward and easy to administer , and that by the 100% retention rate throughout the duration of the study .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   64 We_PPIS2 also_RR found_VVD that_CST the_AT PCQ_NP1 demonstrated_VVD excellent_JJ reliability_NN1 ,_Y that_CST it_PPH1 is_VBZ straightforward_JJ and_CC easy_JJ to_TO administer_VVI ,_Y and_CC that_CST by_II the_AT 100%_NNU retention_NN1 rate_NN1 throughout_II the_AT duration_NN1 of_IO the_AT study_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   65 It is possible that our findings were biased as a result of the study population we selected ; since the PCQ has not been translated , we enrolled only English-speaking subjects .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   65 It_PPH1 is_VBZ possible_JJ that_CST our_APPGE findings_NN2 were_VBDR biased_VVN@_JJ as_II a_AT1 result_NN1 of_IO the_AT study_NN1 population_NN1 we_PPIS2 selected_VVD@_VVN ;_Y since_CS the_AT PCQ_NP1 has_VHZ not_XX been_VBN translated_VVN ,_Y we_PPIS2 enrolled_VVD only_RR_JJ English-speaking_JJ subjects_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   66 Another possible limitation of our study is that we did not take into account either physical findings or objective measures of cough , and we did not make our own global assessment of any child 's cough status ; instead we relied solely on responses to the questionnaire .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   66 Another_DD1 possible_JJ limitation_NN1 of_IO our_APPGE study_NN1 is_VBZ that_CST we_PPIS2 did_VDD not_XX take_VVI into_II account_NN1 either_RR physical_JJ findings_NN2 or_CC objective_JJ_NN1 measures_NN2 of_IO cough_NN1 ,_Y and_CC we_PPIS2 did_VDD not_XX make_VVI our_APPGE own_DA global_JJ assessment_NN1 of_IO any_DD child_NN1 's_GE cough_NN1 status_NN1 ;_Y instead_RR we_PPIS2 relied_VVD solely_RR on_II responses_NN2 to_II the_AT questionnaire_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   67 Although further validation studies would be helpful , our findings represent an important first step in the development of valid and reliable methods ( where none currently exists ) of measuring the impact of related treatments , such as therapy for occult gastroesophageal reflux in children with chronic cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   67 Although_CS further_JJR@_RRR validation_NN1 studies_NN2 would_VM be_VBI helpful_JJ ,_Y our_APPGE findings_NN2 represent_VV0 an_AT1 important_JJ first_MD step_NN1_VV0 in_II the_AT development_NN1 of_IO valid_JJ and_CC reliable_JJ methods_NN2 (_Y where_CS none_PN currently_RR exists_VVZ )_Y of_IO measuring_VVG the_AT impact_NN1 of_IO related_JJ treatments_NN2 ,_Y such_II21 as_II22 therapy_NN1 for_IF occult_NN1 gastroesophageal_JJ reflux_NN1 in_II children_NN2 with_IW chronic_JJ cough_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   68 Also , further studies comparing PCQ responses with peak flow or spirometry results would be of interest .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   68 Also_RR ,_Y further_JJR@_RRR studies_NN2 comparing_VVG PCQ_NP1 responses_NN2 with_IW peak_NN1 flow_NN1 or_CC spirometry_NN1 results_NN2 would_VM be_VBI of_IO interest_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   69 Previous presentation : The information in this article has been updated from its original presentation as a poster at the American Thoracic Society 's 2006 International Conference ; May 19-24 questionnaire(*) Q1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   69 Previous_JJ presentation_NN1 :_Y The_AT information_NN1 in_II this_DD1 article_NN1 has_VHZ been_VBN updated_VVN from_II its_Z' original_JJ presentation_NN1 as_II_CSA a_AT1 poster_NN1 at_II the_AT American_JJ Thoracic_JJ_NN1 Society_NN1 's_GE_VBZ 2006_MC International_JJ Conference_NN1 ;_Y May_NPM1 19-24_MCMC questionnaire(*)_FO Q1_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   70 How frequent was your child 's cough last night ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   70 How_RGQ@_RRQ frequent_JJ was_VBDZ your_APPGE child_NN1 's_GE cough_NN1 last_MD night_NNT1 ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   71 Extremely Very much Somewhat A little Occasionally Not at all Q2 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   71 Extremely_RR Very_RG much_DA1_RR Somewhat_RR A_RR21 little_RR22 Occasionally_RR Not_XX at_RR21 all_RR22 Q2_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   72 How much did last night 's cough affect your child 's ability to sleep ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   72 How_RGQ@ much_DA1 did_VDD last_MD night_NNT1 's_GE cough_NN1 affect_VV0 your_APPGE child_NN1 's_GE ability_NN1 to_TO sleep_VVI ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   73 Extremely Very much Somewhat A little Occasionally Not at all Q.3 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   73 Extremely_RR Very_RG much_DA1_RR Somewhat_RR A_RR21 little_RR22 Occasionally_RR Not_XX at_RR21 all_RR22 Q.3_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   74 How much did last night 's cough affect your ability to sleep ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   74 How_RGQ@ much_DA1 did_VDD last_MD night_NNT1 's_GE cough_NN1 affect_VV0 your_APPGE ability_NN1 to_TO sleep_VVI ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   75 Extremely Very much Somewhat A little Occasionally Not at all Q4 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   75 Extremely_RR Very_RG much_DA1_RR Somewhat_RR A_RR21 little_RR22 Occasionally_RR Not_XX at_RR21 all_RR22 Q4_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   76 How severe was your child 's cough last night ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   76 How_RGQ@_RRQ severe_JJ was_VBDZ your_APPGE child_NN1 's_GE cough_NN1 last_MD night_NNT1 ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   77 Extremely Very much Somewhat A little Occasionally Not at all Q.5 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   77 Extremely_RR Very_RG much_DA1_RR Somewhat_RR A_RR21 little_RR22 Occasionally_RR Not_XX at_RR21 all_RR22 Q.5_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   78 How bothersome was last night 's cough to your child ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   78 How_RGQ@_RRQ bothersome_JJ was_VBDZ last_MD night_NNT1 's_GE cough_NN1 to_II your_APPGE child_NN1 ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   79 Extremely Very much Somewhat A little Occasionally Not at all ( * ) This version of the pediatric cough questionnaire is slightly modified from the original by Paul et al. n17 Scores decline in 1-point increments from 5 for " Extremely " to 0 for " Not at all .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   79 Extremely_RR Very_RG much_DA1_RR Somewhat_RR A_RR21 little_RR22 Occasionally_RR Not_XX at_RR21 all_RR22 (_Y *_FU )_Y This_DD1 version_NN1 of_IO the_AT pediatric_JJ cough_NN1 questionnaire_NN1 is_VBZ slightly_RR modified_VVN_VVD from_II the_AT original_JJ_NN1@ by_II Paul_NP1 et_RA21 al._RA22 n17_FO Scores_NN2_VVZ@ decline_VV0_NN1 in_II_RP@ 1-point_JJ_NN1 increments_NN2 from_II 5_MC for_IF "_Y Extremely_RR "_Y to_II 0_MC for_IF "_Y Not_XX at_RR21 all_RR22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   80 " Table 1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   80 "_Y Table_NN1_VV0% 1_MC1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   81 Results of the Spearman correlation analysis for test-retest reliability* ) pre-formatted table References ( n1 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   81 Results_NN2 of_IO the_AT Spearman_NN1_NP1 correlation_NN1 analysis_NN1 for_IF test-retest_NN1_JJ reliability*_FO )_Y pre-formatted_ZZ table_NN1 References_NN2 (_Y n1_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   82 ) Schappert SM , Nelson C. National Ambulatory Medical Care Survey ( 142 ) : i-vi , 1-122. ( n2 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   82 )_Y Schappert_VV0_NP1@ SM_NP1 ,_Y Nelson_NP1 C._NP1_ZZ1@ National_JJ Ambulatory_JJ Medical_JJ Care_NN1 Survey_NN1 (_Y 142_MC )_Y :_Y i-vi_MC ,_Y 1-122._MCMC (_Y n2_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   83 ) Cherry DK , Woodwell DA .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   83 )_Y Cherry_NP1 DK_NP1 ,_Y Woodwell_NP1 DA_NN1_FU ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   84 National Ambulatory Medical Care Survey : 2000 summary .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   84 National_JJ Ambulatory_JJ Medical_JJ Care_NN1 Survey_NN1 :_Y 2000_MC summary_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   85 Adv Data 2002 ; ( 328 ) : 1-32. ( n3 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   85 Adv_NN1_NP1@ Data_NN 2002_MC ;_Y (_Y 328_MC )_Y :_Y 1-32._MCMC (_Y n3_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   86 ) Irwin RS , Boulet LP , Cloutier MM , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   86 )_Y Irwin_NP1 RS_NN1 ,_Y Boulet_NP1_NN1 LP_NN1 ,_Y Cloutier_NN1_JJR MM_UH_NNU@ ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   87 Managing cough as a defense mechanism and as a symptom .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   87 Managing_JJ_VVG_NN1 cough_NN1 as_II_CSA a_AT1 defense_NN1 mechanism_NN1 and_CC as_II_CSA a_AT1 symptom_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   88 A consensus panel report of the American College of Chest Physicians .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   88 A_AT1 consensus_NN1 panel_NN1 report_NN1 of_IO the_AT American_JJ College_NN1 of_IO Chest_NN1 Physicians_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   89 Chest 1998 ; 114 ( 2 Suppl Managing ) : 133S-181S. ( n4 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   89 Chest_NN1 1998_MC ;_Y 114_VV0_NN1_JJ (_Y 2_JJ_VV0_NN1 Suppl_NN1_NP1_VV0 Managing_NN1_VVG_JJ )_Y :_Y 133S-181S._NNU (_Y n4_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   90 ) Irwin RS , Curley FJ , French CL .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   90 )_Y Irwin_NP1 RS_NN1 ,_Y Curley_NP1 FJ_NP1 ,_Y French_NP1@_JJ CL_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   91 Chronic cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   91 Chronic_JJ cough_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   92 The spectrum and frequency of causes , key components of the diagnostic evaluation , and outcome of specific therapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   92 The_AT spectrum_NN1 and_CC frequency_NN1 of_IO causes_NN2 ,_Y key_JJ components_NN2 of_IO the_AT diagnostic_JJ evaluation_NN1 ,_Y and_CC outcome_NN1 of_IO specific_JJ therapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   93 Am Rev Respir Dis 1990 ; 141(3):640-7. ( n5 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   93 Am_VBM Rev_NNB Respir_NP1 Dis_NN2 1990_MC ;_Y 141(3):640-7._FO (_Y n5_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   94 ) Irwin RS , Corrao WM , Pratter MR .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   94 )_Y Irwin_NP1 RS_NN1 ,_Y Corrao_NP1 WM_NP1 ,_Y Pratter_NP1 MR_NNB ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   95 Chronic persistent cough in the adult : The spectrum and frequency of causes and successful outcome of specific therapy .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   95 Chronic_JJ persistent_JJ cough_NN1 in_II the_AT adult_NN1 :_Y The_AT spectrum_NN1 and_CC frequency_NN1 of_IO causes_NN2 and_CC successful_JJ outcome_NN1 of_IO specific_JJ therapy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   96 Am Rev Respir Dis 1981 ; 123 ( 4 Pt 1 ) : 413-17. ( n6 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   96 Am_VBM Rev_NNB Respir_NP1 Dis_NN2 1981_MC ;_Y 123_VV0_NN1_JJ (_Y 4_VV0_NN1 Pt_FO 1_MC1 )_Y :_Y 413-17._MCMC (_Y n6_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   97 ) Irwin RS , French CT .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   97 )_Y Irwin_NP1 RS_NN1 ,_Y French_JJ_NN1 CT_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   98 Cough and gastroesophageal reflux : Identifying J Med 2001 ; 111 ( Suppl 8A ) : 45S-50S. ( n7 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   98 Cough_VV0_NN1 and_CC gastroesophageal_JJ reflux_NN1 :_Y Identifying_VVG J_NP1@ Med_VVD@_JJ 2001_MC ;_Y 111_VV0_NN1_JJ (_Y Suppl_NP1_VV0 8A_FO )_Y :_Y 45S-50S._NNU (_Y n7_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0   99 ) Chernick V , Boat T , eds .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0   99 )_Y Chernick_VV0 V_ZZ1 ,_Y Boat_NN1 T_ZZ1 ,_Y eds_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  100 Kendig 's Disorders of the Respiratory Tract in Children .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  100 Kendig_NP1@_NN1 's_GE Disorders_NN2 of_IO the_AT Respiratory_JJ_NP1 Tract_NN1_NP1 in_II Children_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  101 6th ed .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  101 6th_MD ed_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  102 Philadelphia : W.B. Saunders ; 1998. ( n8. ) de Jongste JC , Shields MD .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  102 Philadelphia_NP1 :_Y W.B._NP1 Saunders_NP1 ;_Y 1998._MC (_Y n8._FO )_Y de_NP1_FW Jongste_NP1 JC_NP1 ,_Y Shields_NP1 MD_NNA ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  103 Cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  103 Cough_VV0_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  104 2 : Chronic cough in children .. Thorax 2003 ; 58(11):998-1003. ( n9 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  104 2_MC :_Y Chronic_JJ cough_NN1 in_II children_NN2 .._... Thorax_VV0_NN1 2003_MC ;_Y 58(11):998-1003._FO (_Y n9_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  105 ) Munyard P , Bush A. How much coughing is normal ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  105 )_Y Munyard_NN1_NP1@ P_ZZ1_NP1@ ,_Y Bush_NP1 A._ZZ How_RRQ_RGQ@ much_DA1_RR coughing_NN1@_VVG is_VBZ normal_JJ ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  106 Arch Dis Child 1996 ; 74(6):531-4. ( n10 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  106 Arch_JJ_NN1 Dis_NN2 Child_NN1 1996_MC ;_Y 74(6):531-4._FO (_Y n10_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  107 ) Shann F. How often do children cough ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  107 )_Y Shann_VV0_NP1@ F._NP1 How_RGQ often_RR do_VD0 children_NN2 cough_VVI ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  108 Lancet 1996 ; 384(9029):699-700. ( n11 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  108 Lancet_NP1 1996_MC ;_Y 384(9029):699-700._FO (_Y n11_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  109 ) French CL , Irwin RS , Curley FJ , Krikorian CJ .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  109 )_Y French_NP1@_JJ CL_NP1 ,_Y Irwin_NP1 RS_NN1 ,_Y Curley_NP1 FJ_NP1 ,_Y Krikorian_JJ CJ_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  110 Impact of chronic cough on quality of life .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  110 Impact_NN1 of_IO chronic_JJ cough_NN1 on_II quality_NN1 of_IO life_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  111 Arch Intern Med 1998 ; 158(15):1657-61. ( n12 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  111 Arch_JJ_NN1 Intern_NN1_NP1 Med_VVD@_JJ 1998_MC ;_Y 158(15):1657-61._FO (_Y n12_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  112 ) Rosendahl I. Expense of physician care spurs OTC , self-care market .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  112 )_Y Rosendahl_NP1 I._NP1 Expense_NN1 of_IO physician_NN1 care_NN1 spurs_NN2 OTC_NN1_NP1 ,_Y self-care_JJ_NN1 market_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  113 Drug Topics 1988 ; 132(15):62-3. ( n13 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  113 Drug_NN1 Topics_NN2 1988_MC ;_Y 132(15):62-3._FO (_Y n13_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  114 ) Morice AH .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  114 )_Y Morice_VV0 AH_UH ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  115 Epidemiology of cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  115 Epidemiology_NN1 of_IO cough_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  116 Pulm Pharmacol Ther 2002 ; 15(3):253-9. ( n14 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  116 Pulm_VV0_NP1@ Pharmacol_NP1_NN1 Ther_NP1_NN1 2002_MC ;_Y 15(3):253-9._FO (_Y n14_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  117 ) Couch RB .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  117 )_Y Couch_NN1_VV0% RB_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  118 The common cold : Control ?
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  118 The_AT common_JJ cold_NN1_JJ :_Y Control_NN1_VV0@ ?_Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  119 J Infect Dis 1984 ; 150(2) : .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  119 J_NP1@_ZZ1 Infect_NP1_VV0_NN1 Dis_NN2 1984_MC ;_Y 150(2)_FO :_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  120 Physiology and treatment of cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  120 Physiology_NN1 and_CC treatment_NN1 of_IO cough_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  121 Thorax 1990 ; 45(6):425-30. ( n16 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  121 Thorax_VV0_NN1 1990_MC ;_Y 45(6):425-30._FO (_Y n16_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  122 ) Birring SS , Prudon B , Carr AJ , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  122 )_Y Birring_NP1@_VVG SS_NP1 ,_Y Prudon_NP1 B_ZZ1_NP1@ ,_Y Carr_NP1 AJ_NP1 ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  123 Development of a symptom specific health status measure for patients with chronic cough : Leicester Cough Questionnaire ( LCQ ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  123 Development_NN1 of_IO a_AT1 symptom_NN1 specific_JJ health_NN1 status_NN1 measure_NN1_VV0 for_IF patients_NN2 with_IW chronic_JJ cough_NN1 :_Y Leicester_NP1 Cough_NN1_VV0 Questionnaire_NN1 (_Y LCQ_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  124 Thorax 2003 ; 58(4):339-43. ( n17 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  124 Thorax_VV0_NN1 2003_MC ;_Y 58(4):339-43._FO (_Y n17_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  125 ) Paul IM , Yoder KE , Crowell KR , et al .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  125 )_Y Paul_NP1 IM_Z' ,_Y Yoder_NP1_VV0 KE_NP1_NN1 ,_Y Crowell_NP1 KR_NP1 ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  126 Effect of dextromethorphan , diphenhydramine , and placebo on nocturnal cough and sleep quality for coughing children and their parents .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  126 Effect_NN1 of_IO dextromethorphan_NN1 ,_Y diphenhydramine_VV0_NN1 ,_Y and_CC placebo_NN1 on_II nocturnal_JJ cough_NN1 and_CC sleep_VV0_NN1 quality_NN1 for_IF coughing_VVG children_NN2 and_CC their_APPGE parents_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  127 Pediatrics 2004 ; 114(1) : e85-90. ( n18 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  127 Pediatrics_NN1 2004_MC ;_Y 114(1)_FO :_Y e85-90._MC (_Y n18_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  128 ) Streiner DL , Norman GR .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  128 )_Y Streiner_NN1_NP1@ DL_MC ,_Y Norman_NP1 GR_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  129 Health Measurement Scales : A Practical Guide to Their Development and Use .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  129 Health_NN1 Measurement_NN1 Scales_NN2 :_Y A_ZZ1_AT1@ Practical_JJ Guide_NN1 to_II Their_APPGE Development_NN1 and_CC Use_NN1_VV0 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  130 2nd ed .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  130 2nd_MD ed_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  131 Oxford : Oxford Medical Publications ; 1995. ( n19 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  131 Oxford_NP1 :_Y Oxford_NP1 Medical_JJ Publications_NN2 ;_Y 1995._MC (_Y n19_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  132 ) Chang AB , Newman RG , Phelan PD , Robertson CF. A new use for an old Holter monitor : An ambulatory cough meter .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  132 )_Y Chang_VV0_NN1 AB_FO ,_Y Newman_NP1 RG_NP1 ,_Y Phelan_NP1 PD_NP1 ,_Y Robertson_NP1 CF._VV0 A_ZZ1_AT1@ new_JJ use_NN1 for_IF an_AT1 old_JJ Holter_NP1 monitor_NN1_VV0 :_Y An_AT1 ambulatory_JJ cough_NN1 meter_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  133 Eur Respir J 1997 ; 10(7):1637-9. ( n20 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  133 Eur_NP1@_NN1 Respir_NP1_NN1 J_ZZ1_NP1@ 1997_MC ;_Y 10(7):1637-9._FO (_Y n20_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  134 ) Powell CV , McNamara P , Solis A , Shaw NJ .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  134 )_Y Powell_NP1 CV_NN1 ,_Y McNamara_NP1 P_ZZ1_NP1@ ,_Y Solis_NP1_NN1 A_ZZ1 ,_Y Shaw_NP1 NJ_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  135 A parent completed questionnaire to describe the patterns of wheezing and other Child 2002 ; 87(5):376-9. ( n21 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  135 A_AT1 parent_NN1 completed_VVD_VVN_JJ@ questionnaire_NN1 to_TO describe_VVI the_AT patterns_NN2 of_IO wheezing_VVG_NN1@_JJ@ and_CC other_JJ Child_NN1 2002_MC ;_Y 87(5):376-9._FO (_Y n21_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  136 ) Faniran AO , Peat JK , Woolcock AJ .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  136 )_Y Faniran_NP1@_JJ AO_NP1 ,_Y Peat_NN1 JK_NP1 ,_Y Woolcock_NP1 AJ_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  137 Measuring persistent cough in children in epidemiological studies : Development of a questionnaire and assessment of prevalence in two countries .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  137 Measuring_VVG_JJ@ persistent_JJ cough_NN1 in_II children_NN2 in_II epidemiological_JJ studies_NN2 :_Y Development_NN1 of_IO a_AT1 questionnaire_NN1 and_CC assessment_NN1 of_IO prevalence_NN1 in_II two_MC countries_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  138 Chest 1999 ; 115(2):434-9. ( n22 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  138 Chest_NN1 1999_MC ;_Y 115(2):434-9._FO (_Y n22_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  139 ) French CT , Irwin RS , Fletcher KE , Adams TM .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  139 )_Y French_JJ_NN1 CT_NN1 ,_Y Irwin_NP1 RS_NN1 ,_Y Fletcher_NP1 KE_NP1 ,_Y Adams_NP1 TM_NP1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  140 Evaluation of a cough-specific quality-of-life questionnaire .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  140 Evaluation_NN1 of_IO a_AT1 cough-specific_JJ quality-of-life_JJ_NN1 questionnaire_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  141 Chest 2002 ; 121(4):1123-31. ( n23 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  141 Chest_NN1 2002_MC ;_Y 121(4):1123-31._FO (_Y n23_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  142 ) French CT , Fletcher KE , Irwin RS .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  142 )_Y French_JJ_NN1 CT_NN1 ,_Y Fletcher_NP1 KE_NP1 ,_Y Irwin_NP1 RS_NN1_NNU2 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  143 Gender differences in health-related quality of life in patients complaining of chronic cough .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  143 Gender_NN1 differences_NN2 in_II health-related_JJ_NN1 quality_NN1 of_IO life_NN1 in_II patients_NN2 complaining_VVG of_IO chronic_JJ cough_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  144 Chest 2004 ; 125(2):482-8 .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  144 Chest_NN1 2004_MC ;_Y 125(2):482-8_FO ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  145 By Christopher J. Hartnick , MD ; David Zurakowski , PhD and Kenan Haver , MD From the Department of Otolaryngology , Massachusetts Eye and Ear Infirmary , Boston ( Dr. Hartnick ) ; the Department of Orthopedic Surgery , Children 's Hospital , Boston ( Dr. Zurakowski ) ; and the Division of Pediatric Pulmonary Medicine , Massachusetts General Hospital for Children , Boston ( Dr. Haver ) .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  145 By_II Christopher_NP1 J._NP1 Hartnick_NP1 ,_Y MD_NNA ;_Y David_NP1 Zurakowski_NP1 ,_Y PhD_NNA and_CC Kenan_NP1 Haver_NP1 ,_Y MD_NNA From_II the_AT Department_NN1 of_IO Otolaryngology_NP1_NN1 ,_Y Massachusetts_NP1 Eye_NP1_NN1 and_CC Ear_NN1 Infirmary_NN1 ,_Y Boston_NP1 (_Y Dr._NNB Hartnick_NP1 )_Y ;_Y the_AT Department_NN1 of_IO Orthopedic_JJ_NP1 Surgery_NN1 ,_Y Children_NN2 's_GE Hospital_NN1 ,_Y Boston_NP1 (_Y Dr._NNB Zurakowski_NP1 )_Y ;_Y and_CC the_AT Division_NN1 of_IO Pediatric_JJ Pulmonary_JJ Medicine_NN1 ,_Y Massachusetts_NP1 General_JJ_NN1 Hospital_NN1 for_IF Children_NN2 ,_Y Boston_NP1 (_Y Dr._NNB Haver_NP1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  146 Corresponding author : Christopher J. Hartnick , MD , Associate Professor , Department of Otolaryngology , Massachusetts Eye and Ear .
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  146 Corresponding_JJ_VVG author_NN1 :_Y Christopher_NP1 J._NP1 Hartnick_NP1 ,_Y MD_NNA ,_Y Associate_JJ_VV0 Professor_NN1 ,_Y Department_NN1 of_IO Otolaryngology_NP1_NN1 ,_Y Massachusetts_NP1 Eye_NP1_NN1 and_CC Ear_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  A    0  147 E-mail : **36;18792;TOOLONG
SENTPOS COCA_acad_wlp_2009_10_FILE##4080430 COCA  B    0  147 E-mail_NN1_VV0@ :_Y **36;18792;TOOLONG_FO
